Daesung Microbiological Labs. Co. Ltd (036480) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.027x

Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩972.26 Million ≈ $658.89K USD) by net assets (₩35.42 Billion ≈ $24.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 036480 equity to assets ratio to measure how much of total assets are equity-financed.

Daesung Microbiological Labs. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Daesung Microbiological Labs. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Daesung Microbiological Labs. Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

Daesung Microbiological Labs. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Grand House Mulia Pt JK:HOMI	0.016x
Burcon NutraScience Corporation TO:BU	0.640x
Bimergen Energy Corporation NYSE:BESS	0.086x
CPR Gomu Industrial PCL BK:CPR	0.020x
MDB Capital Holdings, LLC Class A common NASDAQ:MDBH	-0.052x
Zivo Bioscience Inc NASDAQ:ZIVO	0.297x
Rubberex Corporation M Bhd KLSE:7803	0.038x
Destinasi Tirta Nusantara Tbk JK:PDES	0.250x

Annual Cash Flow Conversion Efficiency for Daesung Microbiological Labs. Co. Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Daesung Microbiological Labs. Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩35.42 Billion ≈ $24.00 Million	₩1.41 Billion ≈ $955.61K	0.040x	-33.46%
2024-12-31	₩35.15 Billion ≈ $23.82 Million	₩2.10 Billion ≈ $1.43 Million	0.060x	+281.12%
2023-12-31	₩37.35 Billion ≈ $25.31 Million	₩-1.23 Billion ≈ $-836.14K	-0.033x	-211.04%
2022-12-31	₩38.84 Billion ≈ $26.32 Million	₩1.16 Billion ≈ $783.00K	0.030x	-50.04%
2021-12-31	₩37.00 Billion ≈ $25.08 Million	₩2.20 Billion ≈ $1.49 Million	0.060x	-33.19%
2020-12-31	₩36.31 Billion ≈ $24.61 Million	₩3.24 Billion ≈ $2.19 Million	0.089x	+35.07%
2019-12-31	₩35.09 Billion ≈ $23.78 Million	₩2.32 Billion ≈ $1.57 Million	0.066x	-30.56%
2018-12-31	₩33.01 Billion ≈ $22.37 Million	₩3.14 Billion ≈ $2.13 Million	0.095x	+71.29%
2017-12-31	₩30.30 Billion ≈ $20.53 Million	₩1.68 Billion ≈ $1.14 Million	0.055x	-54.29%
2016-12-31	₩29.01 Billion ≈ $19.66 Million	₩3.52 Billion ≈ $2.39 Million	0.121x	-60.26%
2015-12-31	₩25.09 Billion ≈ $17.01 Million	₩7.66 Billion ≈ $5.19 Million	0.305x	+68.35%
2014-12-31	₩21.14 Billion ≈ $14.32 Million	₩3.83 Billion ≈ $2.60 Million	0.181x	+89.22%
2013-12-31	₩19.72 Billion ≈ $13.36 Million	₩1.89 Billion ≈ $1.28 Million	0.096x	-18.93%
2012-12-31	₩19.73 Billion ≈ $13.37 Million	₩2.33 Billion ≈ $1.58 Million	0.118x	--

About Daesung Microbiological Labs. Co. Ltd

KQ:036480 Korea Biotechnology

Market Cap

$16.61 Million

₩24.51 Billion KRW

Market Cap Rank

#25682 Global

#1903 in Korea

Share Price

₩6450.00

Change (1 day)

-0.46%

52-Week Range

₩5590.00 - ₩9880.00

All Time High

₩27216.09